|

Leuprorelin Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 2

Top Sponsors

  • University Medical Center Groningen1
  • Gustave Roussy, Cancer Campus, Grand Paris1

Indications

  • Polycystic Liver Disease1
  • Autosomal Dominant Polycystic Kidney1
  • Liver Disease1
  • Breast Cancer1
  • Cancer1

Other2 trials

A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease
Phase 2
A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.